Back to search

The use of halogenated thymidine analogs as clinical radiosensitizers: Rationale, current status, and future prospects: Non-hypoxic cell sensitizers

Data up to Jan 2025

Published1984
Citations110
References44

Total Citations Per Year

Abstract

References (44)

Monoclonal Antibody to 5-Bromo- and 5-Iododeoxyuridine: A New Reagent for Detection of DNA Replication

1982 • 2,648 citations

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas

1978 • 1,663 citations

GENETICS OF HUMAN CELL LINES

1960 • 649 citations

The Pharmacological Basis of Therapeutics

1966 • 435 citations

Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.

1983 • 337 citations

Synthesis and biological activities of iododeoxyuridine, an analog of thymidine

1959 • 332 citations

Radiation response of mammalian cells grown in culture

1963 • 285 citations

The Lesions Produced by Ultraviolet Light in DNA Containing 5-Bromouracil

1973 • 233 citations

The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells.

1977 • 210 citations

Nonlinear pharmacokinetic models for 5-fluorouracil in man: Intravenous and intraperitoneal routes

1980 • 181 citations

Principles of internal medicine

1955 • 177 citations

The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat.

1962 • 175 citations

X-ray sensitization by halopyrimidines.

1974 • 151 citations

Modern Trends in Radiotherapy 1.

1968 • 149 citations

INTRA-ARTERIAL 5-BROMODEOXYURIDINE AND X-RAY THERAPY

1967 • 143 citations

Failure of High Dose 5-Iodo-2′-Deoxyuridine in the Therapy of Herpes Simplex Virus Encephalitis

1975 • 135 citations

Molecular Radiobiology of Human Cell Lines: V. Comparative Radiosensitizing Properties of 5-Halodeoxycytidines and 5-Halodeoxyuridines

1963 • 127 citations

Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors.

1984 • 106 citations

Radiosensitization of Brain Tumor Cells with a Thymidine Analogue (Bromouridine)

1968 • 105 citations

The fate of 5-bromodeoxyuridine, 5-bromodeoxycytidine, and 5-iododeoxycytidine in man.

1963 • 99 citations

A phase i study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation

1984 • 99 citations

Initial clinical studies with 5-iodo-2'-deoxyuridine.

1961 • 95 citations

Pharmacokinetics of the fluoropyrimidines: implications for their clinical use

1976 • 89 citations

Radiosensitization of Malignant Brain Tumours with Bromouridine (Thymidine Analogue)

1969 • 85 citations

Radiation Sensitivity of Cultured Human Glioblastoma Cells

1977 • 83 citations

Development of a clonogenic cell assay for human brain tumors

1978 • 82 citations

Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR)

1983 • 70 citations

Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.

1984 • 69 citations

Preferential Radiosensitization of Mouse Sarcoma Relative to Normal Skin by Chronic Intra-Arterial Infusion of Halogenated Pyrimidine Analogs<xref ref-type="fn" rid="FN2">2</xref>

1971 • 63 citations

The Photochemistry of 5-Bromouracil and 5-lodouracil in DNA

1980 • 57 citations

Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR

1984 • 42 citations

Antiviral iodinated pyrimidine deoxyribonucleosides: 5-iodo-2′-deoxyuridine; 5′-iodo-2′-deoxycytidine; 5-iodo-5′-amino-2′,5′-didoxyuridine

1979 • 39 citations

Experimental and Clinical Studies of Radiosensitizers in Brain Tumors, with Special Reference to BUdR-Antimetabolite Continuous Regional Infusion-Radiation Therapy (BAR therapy)

1965 • 36 citations

The effect of 5-iododeoxyuridine upon the growth of some transplantable rodent tumors.

1960 • 34 citations

Potentiation of X-Ray Killing by 5-Bromodeoxyuridine in Chinese Hamster Cells: A Reduction in Capacity for Sublethal Damage Accumulation

1971 • 34 citations

High‐dose intravenous and hepatic artery infusions of thymidine

1978 • 32 citations

Comparison of Intravenous and Intra-arterial Pyrimidine Infusion as a Means of Radiosensitizing TumorsIn Vivo

1977 • 31 citations

Clinical and pharmacological studies with 5-iodo-2'-deoxycytidine.

1963 • 28 citations

INCORPORATION OF I-125-LABELED IODODEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF MURINE AND HUMAN TISSUES FOLLOWING THERAPEUTIC DOSES.

1963 • 28 citations

Ambulatory pump infusion devices for hepatic artery infusion.

1983 • 21 citations

Long‐term intraarterial chemotherapy infusion of ambulatory head and neck cancer patients

1982 • 17 citations

Effect of Radiation-Sensitizing Agents in Radiation Therapy of Mouse Mammary Carcinoma

1970 • 15 citations

Continuous Irradiation of P388F Lymphomain VitroSensitization by 5-iodo-2′-deoxyuridine

1967 • 12 citations

Heterologous Transplantation for Demonstration of the Oncogenic Effect of Rous Sarcoma Virus

1960 • 8 citations

Cited By (0)

No citing papers found in database

The use of halogenated thymidine analogs as clinical radiosensitizers: Rationale, current… (1984) – International Journal of Radiation Oncology*Biology*Physics | Metascience Observatory Explorer